Corporate News Update – 21 October 2026
Newamsterdam Pharma (NAMS)
- Trading performance: The Newamsterdam Pharma share price increased 5.03 % during the 24‑hour period ending at 02:43 PM Central Europe on Wednesday, 21 October 2026.
- Current price: USD 21.50 on major exchanges.
- Outstanding shares: 119.7 million.
- Market capitalization: USD 2.50 billion.
- Volume: USD 23.3 million of shares were traded in the last 24 hours.
- Month‑to‑date change: The share price has fallen 4.78 % since the close of the previous month.
- Moving average: The simple moving average over the last 200 trading days is USD 30.33.
- 52‑week range: The highest price was USD 42.20 on 05 November 2026; the lowest was USD 19.58 on 10 April 2026.
Related Stock Movements – 24 Hours
| Stock | Ticker | % Change | Current Price | Market Cap | P/E | Notes |
|---|---|---|---|---|---|---|
| Signify | LIGHT.AS | –0.21 % | EUR 14.18 | EUR 1.70 bn | 11.1 | – |
| Basic‑fit | BFIT.AS | +2.77 % | EUR 30.70 | EUR 2.00 bn | 43.37 | – |
| Uniqure | UQ1.F | –0.70 % | EUR 20.15 | EUR 1.40 bn | – | UBS raised target price to USD 48; mixed analyst views; higher loss than projected, revenue above estimates. |
| Fugro | FUR.AS | –2.49 % | EUR 7.28 | EUR 803.8 mn | – | Waratah Minerals reported encouraging gold mineralisation at the Goldenclad site; drilling to continue. |
| Redcare Pharmacy | RDC.DE | –2.25 % | EUR 77.95 | EUR 1.60 bn | – | Recent short‑sale filings indicate continued short positions; no new corporate announcements. |
Company Profile – Newamsterdam Pharma
Newamsterdam Pharma Co NV is a late‑stage clinical biopharmaceutical company headquartered in Naarden, the Netherlands. The firm focuses on developing oral small‑molecule therapies for cardiovascular and metabolic diseases, targeting patients in the United States and Europe. The company’s shares are listed on the Nasdaq exchange. More information can be found on the company’s website: www.newamsterdampharma.com .
